Artwork

Content provided by Psychedelics Today, LLC and Psychedelics Today. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Psychedelics Today, LLC and Psychedelics Today or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

PT514 – Breaking Through Bureaucracy: Can D.C. Embrace Evidence-Based Drug Policy?, with Senator Tom Daschle and Charlie Panfil

58:53
 
Share
 

Manage episode 419468994 series 1088550
Content provided by Psychedelics Today, LLC and Psychedelics Today. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Psychedelics Today, LLC and Psychedelics Today or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode, Joe interviews two members of The Daschle Group: Founder and CEO, Senator Tom Daschle; and Public Policy Advisor, Charlie Panfil.

As Senator Daschle served in the House of Representatives for eight years (starting in 1978) and the Senate for 21, he was deep in the War on Drugs at its peak, and thankfully, as seen with so many of his constituents in recent years, the data and personal stories of so many healed people has broken through the propaganda and made him a strong advocate for psychedelic-assisted therapy. While minds are changing and progress is happening before our eyes (the majority of substances the FDA is currently researching for psychiatric indications contain some form of psychedelic ingredient), government bureaucracy, a severe lack of communication between the FDA and DEA, and decades of lies are still massive roadblocks. How do we address all of this while advancing research?

They discuss:

  • The need to develop a partnership between the public and private sectors, mostly for the cost of treatments
  • The DEA’s place in all of this: If they’re essentially a law enforcement agency, why are they involved in the safety and efficacy of medical treatments?
  • The STATES Act, the Breakthrough Therapies Act, and how they can affect research
  • Why we need to move past relying on opioids, and instead, embrace a science-based drug policy

and more! For links, head to the show notes page.

  continue reading

645 episodes

Artwork
iconShare
 
Manage episode 419468994 series 1088550
Content provided by Psychedelics Today, LLC and Psychedelics Today. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Psychedelics Today, LLC and Psychedelics Today or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode, Joe interviews two members of The Daschle Group: Founder and CEO, Senator Tom Daschle; and Public Policy Advisor, Charlie Panfil.

As Senator Daschle served in the House of Representatives for eight years (starting in 1978) and the Senate for 21, he was deep in the War on Drugs at its peak, and thankfully, as seen with so many of his constituents in recent years, the data and personal stories of so many healed people has broken through the propaganda and made him a strong advocate for psychedelic-assisted therapy. While minds are changing and progress is happening before our eyes (the majority of substances the FDA is currently researching for psychiatric indications contain some form of psychedelic ingredient), government bureaucracy, a severe lack of communication between the FDA and DEA, and decades of lies are still massive roadblocks. How do we address all of this while advancing research?

They discuss:

  • The need to develop a partnership between the public and private sectors, mostly for the cost of treatments
  • The DEA’s place in all of this: If they’re essentially a law enforcement agency, why are they involved in the safety and efficacy of medical treatments?
  • The STATES Act, the Breakthrough Therapies Act, and how they can affect research
  • Why we need to move past relying on opioids, and instead, embrace a science-based drug policy

and more! For links, head to the show notes page.

  continue reading

645 episodes

Todos los episodios

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide